LoginRegister
    Irish drug trial technology firm Teckro wins $25 million injectionIrish drug trial technology firm Teckro wins $25 million injection
    No selection process-ICMR, Pfizer collaboration on AMR project draws Objections from industryNo selection process-ICMR, Pfizer collaboration on AMR project draws Objections from industry
    Exceptional Losses: Fortis reports consolidated net loss of Rs 180 crore for December quarterExceptional Losses: Fortis reports consolidated net loss of Rs 180 crore for December quarter
    Sun Pharma Q3 profit rises 49 percent at Rs 1242 croreSun Pharma Q3 profit rises 49 percent at Rs 1242 crore
    Fortis appoints Vivek Kumar Goyal as Chief Financial OfficerFortis appoints Vivek Kumar Goyal as Chief Financial Officer
    Lupin gets FDA nod for Fluoxetine to treat depressive disordersLupin gets FDA nod for Fluoxetine to treat depressive disorders
    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugsAYUSH ministry launches e-AUSHADHI portal for online licensing of drugs
    Mediclaim for Experimental therapies-naturopathy, acupressure, acupuncture cannot be denied: Consumer ForumMediclaim for Experimental therapies-naturopathy, acupressure, acupuncture cannot be denied:...
    Dr Agarwal Group raises Rs 270 crore from Temasek to double eye hospitalsDr Agarwal Group raises Rs 270 crore from Temasek to double eye hospitals
    Zydus receives USFDA approval for hypertension drug combo Triamterene, Hydrochlorothiazide CapsulesZydus receives USFDA approval for hypertension drug combo Triamterene, Hydrochlorothiazide Capsules
    Dr Reddys shares plunge nearly six percent after 11 observations by USFDADr Reddys shares plunge nearly six percent after 11 observations by USFDA
    Mylan launches Advair generic at 70 percent discount in USMylan launches Advair generic at 70 percent discount in US
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X